
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Extracts of black tea knocked out the cold sore-causing herpes virusin recent lab studies at the Mount Sinai School